Emmxmwmmnuwu“
`
`-
`
`mmnmnmxxnwxmkwmx\m\\m\\\\\\\\\\\w\\\\\\\x\\\\\\\\\\\\\\\m\m\\\w“\w\\\m\
`
`\\\\\\\\m\\\\\\\\\\
`
`E haraby FEWGRQ 3:9 prawigus 99mm 3? aims-nay givsa in aha appiimflch sfienétifiad in we smashes: aiaéamam mafia:
`
`, 3‘? QFR 3mmmmm
`iharfiby agamém:
`
`' chtiiismrs assfisimm with {ha cusmmssr Numbsar;
`
`§
`
`Wflififiififi (1 1-38}
`Asmm 1%? use 25:9th 1113912531 3. was 93351-632335
`w.
`us. Pgtema 53m: mumm {mm as. mmamam £3? cwmaficfi
`.
`.
`‘
`‘
`.
`1‘ }‘~‘
`1
`l
`
`fim-YW WAN-wk fiwfimfimkx 5:; 133% n¢§mszss w Nfirfiia‘efiéfic WNW! Rt) a @59an a? inmasian nm 3': m1 mw was: {3553: mm
`-
`
`
`PQWER SEW: fifi’flRNEY "FEE Pfiflfififiififi figFPLfifififififig SEFGRE YRE LESFEQ
`
`
`xm\\\\\\\\\\\\\\\\\m\m\\\\\\x\\\\m\\m\\\mxxxmxxxxxxx
`
`xWxxxxxxxxxxx\\\\\\\\\\\\\\\\\\\\\\\\ \wmmxxmxxxy
`
`\\\WK\\\\\\\\\\\\\\\W\\\W\\\\\\\"K\\\\'\\\V\'\'\"\'\'\'\'\'\'\"(A'\'\'\'\'\'\\'\'\'\'\'\'\'\\'\'\'\'\'\'\'\\'\'\'\'\'\'\'\\'\'\'\\\\\\\\\\\\\\\W\\M\\\\\\ Wmmmmxmmxxxxxxxxxxmxxxxxm’x’mw
`
`
`
`
`
`
`
`
`
`
`i
`
`3
`
`1233923
`E
`E\\\\\.\\\.\.\\\\\\\\.\.\.\\\\\\\\\\\\\\\\\\\\\\........
`1 @mséfiésnatig} named macaw (if mam than tan mien? gis'afiiiémam am 1% ha fifif‘fififl. 391m é gamma: rumba: mass? Em Emmi}:
`
`
`
`'
`figgéairaticn
`H
`fiagéaimfisn
`
`N ‘ Eager
`Mummy
`
`
`
`
`Mama
`
`5
`
`-
`
`
`Mama
`
`u;”.”””yyyuuyaa]é,
`
`u»»»»»»»»,m,w,
`
`W\\\\\\\\\\\\\\\\\\\\\\\\\\\Vx‘sxxxm‘K‘K‘Kxwa-x ....... W\\\\\\\\\\\\\\\\\\\\
`1as! atearnayia) or suganifis} fies mgmsmni Shes unfiemignafi mime €118 Unifiafi Sissies Pagan: am: desmark 9mm (USMQ in wnnswnn M???
`i any first! a?! smart? awiimiims asmgnad ESE}! Yes 1m ufifissnsignsé ascemsmg 1:) ins: US$311} asauignmeni magma a! aaaignmgm fiQEHmSfiifi
`afiachad £33 614% farm En ascma’danas: wiih 37 CFR 3231331 \\\\\\\\\\\\\\\\\»muxmxxxxx
`
`
`
`Piagsa changa 2m mrmspafidwm adéreas far 323 agpiimfiian identifier! in the afiacfiggtatemani under 3? GFR 3mm} :0:
`
`V 511% afidmsfi agnsacigtm with Gamma? Numbar;
`123223
`(M?
`E --““....““....-.w>,_,,‘.‘.........‘m“n"‘““““M\M“““““\\“~~~~~~~~~“\««“‘“«"""“‘«u"““....--uuuuuxuu‘uunxuuu‘“x“‘mxxxxxxxxxxxxxxxxxx““xx““\“«««“«\“v""-"““s“ssssss-~“~u\\\
`‘
`I.
`Firm :3?
`s
`anfiwéduai Mama E“NWWEW
`swarms
`
`
`
`“w“mmmwwmm
`
`,....,,»"J
`
`w“\\\\\\--\\\\\\K\\\\\\\\.\.\.\.\\\xx“nn‘“““““‘““““\\\\\\\\\?\\\\\\\\\\\\\\\\\\\\\\\\\ ‘“‘uu“‘«u........‘““‘\\\\“\~»>, """""“‘?~“N“““\““wn~.~-.-.““x“»»---««W‘“«“\““«x‘x‘m_
`
`,“““\“‘_»‘_‘_____ V.».“fix“...‘““““W““\““““~-.~“~“«\»»»»“““““«« V““««««““uxuxu- \‘n‘nvnuun“‘wnumnnxmm“‘ ~wnxx““\\~x““‘““““‘~""""««ssssssss\\\\\\\\\\»»»»x
`We
`zap
`m
`
`\mexwuxxxnnwfimnnxwmm
`
`: Sawfly .
`flaiapham
`Efiasignaé Mamas and Afiafiresss:
`
`
`
`SASF Want $¢Eence Gmksimi
`
`6?€3§§ Ludwigghafefi
`Gamma;
`
`
`
`
` \\\\\\\<§\\WW§M§\M\ ““99"“
`new aifi'éhia mm isggaiharwifih a ammmm asmrté‘}? cm 3333:; {Mm Pmigaiaa'm mgsgiwimifi E3 wauiwfi m m
`5131338 522 mach agfifificfliafi En whfinfis 2m Sam: 13 meg, “ma améamwfi gamma? 3? SW. 333%} mm? 523% mmsistafi by mm :31“
`gm gmsflfiamm mmissmfi h? was: mm éf mg wmfifiififi :smnflimmr- Es saihsfimd is; am am mmw m fins amfigma,
` \\\\\\\W),\)),\.\.\.\Km\m\\\\\W\\\\\\\\\\\\\W\\\\\\\\\\\ r
`
`: “\“
`and mm £§$k§§§xf§t gm xwiimfim Er: Essmsia £3:ng Emma“? fi§§w§§ :13 a: 1:; WW:
`
`""" 31%”qu {2f Amiga
`Rama:
`
`
`\
`This insx‘i'sflfinsgwmm §§§g§smm and {we is 5ss§p¥i¢ifi§a=‘w is aumurimj m ac: at: Magma“ the migmce
`\\\W\WV\5W\W\\\
`\x\ V V
`‘
`W\\\V\\\\\V\W\\\
`I?
`‘
`“
`
`
`
`\\W\
`
`
`
`
`
`
`fisgnsium
`..§\‘
`‘ E9323
`2%;
`.
`“WM“
`‘mnm.
`\§<W\5555555\\\\\~.-¢-¢v----1x-~xx\\\\\w\\\\\\NN"~\\\\'~'i'i\\\\\\\\\\\\VV""“\x\\\\s\ss\.-V‘.‘.“\\\\
`'
`
`
`
`
`
`
`
`
`m‘m‘uw»Tmm» *W‘
`.
`‘K
`“““ \x .
`‘v V37
`~
`\
`‘ 1
`
`
` \
`\‘
`‘\\\\\\§ »
`'
`\ .
`‘\\‘~ ‘
`~.\\“\‘\§ .\
`
`
`
`NW ““3
`*
`* ‘\
`®Taiswhmm
`‘
`
`'
`'
`‘
`'-
`‘1
`' ‘--'~\:u
`,\‘- x ‘
`'é‘ .\
`_\-,
`
`3
`T1353
`W.
`xxx\\\\\\\\\m\\\\\\i§m\\\\\\\\xm’xxxwxxxmmxm»)>\\\W\m\\m\\\\\\\m\\\\\u
`\xx“mm».\\\\\\\\\'«\\m\\\\\\\\\\\\\\\\\\\~W\\\\\~<\\\\\\\\\\\\\\\\\\\\w\\\“s«mugs»!
`
`‘\ $5M“ \\\\ ~ ~\\$\\\~ \“gmx
`\~‘ “AS ‘ “S§S\>S\§k\§s\&:\s
`
`1 of 1119
`1 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`Docket No.: 074017—0013—01—US
`
`(PATENT)
`
`In re Patent Application of:
`Petra CIRPUS et al.
`
`Application No.: Not Yet Assigned
`
`Confirmation No.: N/A
`
`Filed: Concurrently Herewith
`
`Art Unit: N/A
`
`For: METHOD FOR PRODUCING
`POLYUNSATURATED FATTY ACIDS
`
`Examiner: Not Yet Assigned
`
`INFORMATION DISCLOSURE STATEMENT {IDSQ
`
`Commissioner for Patents
`
`PO. Box 1450
`
`Alexandria, VA 22313—1450
`
`Dear Sir:
`
`Pursuant to 37 CFR 1.56, 1.97 and 1.98, the attention of the Patent and Trademark Office
`
`is hereby directed to the references listed on the attached PTO/SB/08. It is respectfully requested
`
`that the information be expressly considered during the prosecution of this application, and that
`
`the references be made of record therein and appear among the “References Cited” on any patent
`
`to issue therefrom.
`
`This Information Disclosure Statement accompanies the new continuation patent
`
`application submitted herewith and corresponds to the Information Disclosure Statements
`
`previously submitted or cited in parent Application Serial No. 12/280,090.
`
`Copies of the references on the PTO/SB/08 are not provided herewith pursuant to 37 CFR
`
`§ 1.98(d), because the references have been previously cited or submitted in parent Application
`
`Serial No. 12/280,090.
`
`In accordance with 37 CFR 1.97(g), the filing of this Information Disclosure Statement
`
`shall not be construed to mean that a search has been made or that no other material information
`
`as defined in 37 CFR 1.56(a) exists. In accordance with 37 CFR 1.97(h), the filing of this
`
`Information Disclosure statement shall not be construed to be an admission that any patent,
`
`2 of 1119
`2 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Application No.: Not Yet Assigned
`
`Docket No.: 074017—0013—01—US
`
`publication or other information referred to therein is “prior art” for this invention unless
`
`specifically designated as such. Moreover, Applicant understands that the Examiner will make
`
`an independent evaluation of the cited documents.
`
`It is submitted that the Information Disclosure Statement is in compliance with 37 CFR
`
`1.98 and the Examiner is respectfully requested to consider the listed references.
`
`Applicant believes no fee is due with this submission. However, if a fee is due, the
`
`Director is hereby authorized to charge our Deposit Account No. 50—0573, under Order No.
`
`074017—0013—01—US, from which the undersigned is authorized to draw.
`
`Respectfully submitted,
`
`By_/ Hui-21L (Wu /
`Hui—Ju Wu, Ph.D.
`
`Registration No.: 57,209
`Drinker Biddle & Reath LLP
`
`222 Delaware Ave., Ste. 1410
`
`Wilmington, Delaware 19801—1621
`(302) 467—4260
`
`(302) 351—6938 (Fax)
`Attorney for Applicant
`
`#85,080, 132
`
`2
`
`3 of 1119
`3 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`
`
`
`
`
`
`a. :| Computer Readable Form (CRF)
`b. :l Specification Sequence Listing on:
`i. D CD-ROM or CD-R (2 copies); or
`ii. |:| Paper
`c. D Statements verifying identity of above copies
`*Note:
`(1) Benefit claims under 37 CFR 1.78 and foreign priority claims under 1.55 must be included in an Application Data Sheet (ADS).
`(2) For applications filed under 35 USC. 111, the application must contain an ADS specifying the applicant if the applicant is an
`assignee, person to whom the inventor is under an obligation to assign, or person who otherwise shows sufficient proprietary
`interest in the matter. See 37 CFR 1.46(b).
`
`PTO/AlA/15 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number
`
`UTILITY
`
`PATENT APPLICATION
`
`TRANSMITTAL
`
`(Only for new nonprovisional applications under 37 OFF! 1.53(b))
`
`APPLICATION ELEMENTS
`See MPEP chapter 600 concerning utility patent application contents.
`
`METHOD FOR PRODUCING POLYUNSATURATED
`FATTY ACIDS
`
`Express Mail Label N0.—
`Commissioner for Patents
`m 30x145o
`Alexandria VA 22313_1450
`
`ADDRESS To.
`'
`
`FeeT'ansmitta' F°rm
`(PTO/SB/17 or equivalent)
`Applicant asserts small entity status.
`See 37 CFR 127
`Applicant certifies micro entity status. See 37 CFR 1.29.
`Applicant must attach form PTO/SB/15A or B or equivalent.
`
`90
`[Total pages
`Specification
`Both the claims and abstract must start on a new page.
`{See MPEP § 608.01(a) for information on the preferred arrangement)
`
`2,
`3
`
`4.
`
`ACCOMPANYING APPLICATION PAPERS
`
`10.
`
`D -
`AssIgnment Papers
`(cover sheet & document(s))
`
`Name of Assi nee
`
`[Total Sheets
`5. D Drawing(s) (35 USC. 113)
`4
`[Total Pages
`6. Inventor’s Oath or Declaration
`(including substitute statements under 37 OFF? 1.64 and assignments
`serving as an oath or declaration under 37 OFF? 1.63(e))
`
`.
`
`.
`
`—
`
`37 CFR 3'73“) Statement
`(when there Is an assignee)
`
`Power of Attorney
`
`English Translation Document (if applicable)
`
`7.
`
`Newly executed (original or copy)
`a.
`b. E A copy from a prior application (37 CFR 1.63(d))
`X Application Data Sheet
`* See note below.
`See 37 CFR 1.76 (PTO/AlA/14 or equivalent)
`CD-ROM or CD-R
`in duplicate, large table, or Computer Program (Appendix)
`
`:| Landscape Table on CD
`Nucleotide and/or Amino Acid Sequence Submission
`(if applicable, items a. — c. are required)
`
`
`
`. X Information DisclosureStatement
`(pTo/SB/OB or PTo_1449)
`D Copies of citations attached
`Preliminary Amendment
`
`Return Receipt Postcard
`(MPEP § 503) (Should be specifically itemized)
`
`Certified Copy of Priority Document(s)
`(if foreign priority is claimed)
`
`Nonpublication Request
`Under 35 U.S.C. 122(b)(2)(B)(i). Applicant must attach form PTO/SB/35
`or eqUiva'em'
`Text File of Sequence Listing Submitted via EFS
`Web
`
`. X
`
`19. CORRESPONDENCE ADDRESS
`
`I The address associated with Customer Number:
`123223
`on El Correspondence address below
`.—
`.—
`-—————
`-—————
`/Hui-Ju Wu/
`m September 6, 2016
`-
`R
`'t t'
`N .
`HUI-Ju Wu, Ph.D.
`57,209
`
`N
`
`#85,078,564
`
`4 of 1119
`4 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Application Data Sheet
`
`Inventor Information
`
`Inventor Number:
`
`Given Name:
`
`Family Name:
`
`City of Residence:
`
`Country of Residence:
`
`1
`
`Petra
`
`CIRPUS
`
`Mannheim
`
`Germany
`
`Street of mailing address:
`
`Landteilstr. 12
`
`City of mailing address:
`
`Country of mailing address:
`
`Postal or Zip Code of mailing address:
`
`Inventor Number:
`
`Given Name:
`
`Family Name:
`
`City of Residence:
`
`Country of Residence:
`
`Street of mailing address:
`
`City of mailing address:
`
`Country of mailing address:
`
`Postal or Zip Code of mailing address:
`
`Mannheim
`
`Germany
`
`68163
`
`2
`
`Jérg
`
`BAUER
`
`Limburgerhof
`
`Germany
`
`Maxburgstr. 6
`
`Limburgerhof
`
`Germany
`
`67117
`
`Inventor Number:
`
`Given Name:
`
`Xiao
`
`#85,o78,563
`
`Page # 1
`
`5 of 1119
`5of1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSI RO Exhibit 1009
`
`

`

`Family Name:
`
`City of Residence:
`
`QIU
`
`Saskatoon
`
`State or Province of Residence:
`
`SK
`
`Country of Residence:
`
`Canada
`
`Street of mailing address:
`
`403 Kendardine Road
`
`City of mailing address:
`
`State or Province of mailing address:
`
`Country of mailing address:
`
`Postal or Zip Code of mailing address:
`
`lnventor Number:
`
`Given Name:
`
`Family Name:
`
`City of Residence:
`
`Saskatoon
`
`SK
`
`Canada
`
`S7N 385
`
`Guohai
`
`WU
`
`Saskatoon
`
`State or Province of Residence:
`
`SK
`
`Country of Residence:
`
`Canada
`
`Street of mailing address:
`
`2103 Kenderdine Road
`
`City of mailing address:
`
`State or Province of mailing address:
`
`Country of mailing address:
`
`Postal or Zip Code of mailing address:
`
`lnventor Number:
`
`Given Name:
`
`#85,078,563
`
`Saskatoon
`
`SK
`
`Canada
`
`S7N 385
`
`Bifang
`
`Page # 2
`
`6 of 1119
`60f1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSI RO Exhibit 1009
`
`

`

`Family Name:
`
`City of Residence:
`
`CHENG
`
`Saskatoon
`
`State or Province of Residence:
`
`SK
`
`Country of Residence:
`
`Canada
`
`Street of mailing address:
`
`PBI, 110 Gymnasium Road
`
`City of mailing address:
`
`State or Province of mailing address:
`
`Country of mailing address:
`
`Postal or Zip Code of mailing address:
`
`lnventor Number:
`
`Given Name:
`
`Family Name:
`
`City of Residence:
`
`Saskatoon
`
`SK
`
`Canada
`
`S7N 0W9
`
`6
`
`Martin
`
`TRUKSA
`
`Saskatoon
`
`State or Province of Residence:
`
`SK
`
`Country of Residence:
`
`Canada
`
`Street of mailing address:
`
`14439 47 Avenue NW.
`
`City of mailing address:
`
`Country of mailing address:
`
`Postal or Zip Code of mailing address:
`
`lnventor Number:
`
`Given Name:
`
`Family Name:
`
`#85,078,563
`
`Edmonton
`
`Canada
`
`T6H OBQ
`
`Tom
`
`WETJEN
`
`Page # 3
`
`7 of 1119
`7of1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSI RO Exhibit 1009
`
`

`

`City of Residence:
`
`Country of Residence:
`
`Mannheim
`
`Germany
`
`Street of mailing address:
`
`Meerwiesenstrasse 21
`
`City of mailing address:
`
`Country of mailing address:
`
`Mannheim
`
`Germany
`
`Postal or Zip Code of mailing address:
`
`68163
`
`Correspondence Information
`
`Correspondence Customer Number:
`
`123223
`
`Application Information
`
`Application Type:
`
`Subject Matter:
`
`CD-ROM or CD-R?:
`
`Regular
`
`Utility
`
`None
`
`Sequence submission?:
`
`Text File via EFS Web
`
`Computer Readable Form (CRF)?:
`
`See Text File via EFS Web
`
`Title:
`
`METHOD FOR PRODUCING
`
`POLYUNSATU RATED FATTY
`
`ACIDS
`
`Attorney Docket Number:
`
`074017-0013-01-US
`
`Request for Early Publication?:
`
`Request for Non-Publication?:
`
`Small Entity?:
`
`Petition included?:
`
`No
`
`No
`
`No
`
`No
`
`Portions or all of the application associated with
`
`No
`
`#85,078,563
`
`Page # 4
`
`8 of 1119
`8 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`this Application Data Sheet may fall under a
`
`Secrecy Order pursuant to 37 CFR 5.2::
`
`This application (1) claims priority to or the
`
`No
`
`benefit of an application filed before March 16,
`
`2013 and (2) also contains, or contained at any
`
`time, a claim to a claimed invention that has an
`
`effective filing date on or after March 16, 2013::
`
`Representative Information
`
`Representative Customer Number::
`
`123223
`
`Domestic Priority Information
`
`Application::
`
`Continuity Type::
`
`Parent Application::
`
`Parent Filing Date::
`
`This Application
`
`Continuation of
`
`12/280,090
`
`08/20/08 12/280,090
`
`National Stage of
`
`PCT/EP2007/051675
`
`02/21/07
`
`Foreign Priority Information
`
`European Patent Office
`
`061203097
`
`Application number::
`
`Filing Date::
`
`Priority Claimed::
`
`09/07/06
`
`Applicant Information
`
`Applicant Number::
`
`Applicant Type::
`
`1
`
`Assignee
`
`Organization Name::
`
`BASF Plant Science GmbH
`
`Street of mailing address::
`
`Carl-Bosch-Str. 38
`
`#85,078,563
`
`Page # 5
`
`9 of 1119
`9 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`City of mailing address::
`
`Ludwigshafen
`
`Country of mailing address::
`
`Germany
`
`Postal or Zip Code of mailing address::
`
`67056
`
`Authorization or Opt-Out of Authorization to Permit Access
`
`When this Application Data Sheet is properly signed and filed with the application, applicant has provided written
`authority to permit a participating foreign intellectual property (IP) office access to the instant application-as-filed
`(see paragraph A in subsection 1 below) and the European Patent Office (EPO) access to any search results from
`the instant application (see paragraph B in subsection 1 below).
`
`Should applicant choose not to provide an authorization identified in subsection 1 below, applicant must opt-out of
`the authorization by checking the corresponding box A or B or both in subsection 2 below.
`
`NOTE: This section of the Application Data Sheet is ONLY reviewed and processed with the INITIAL filing of an
`application. After the initial filing of an application, an Application Data Sheet cannot be used to provide or rescind
`authorization for access by a foreign IP office(s).
`Instead, Form PTO/SB/39 or PTO/SB/69 must be used as
`appropriate.
`
`1. Authorization to Permit Access by a Foreign Intellectual Property Office(s)
`
`A. Prioriy Document Exchange (PDX) - Unless box A in subsection 2 (opt-out of authorization) is checked, the
`undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO), the Japan Patent
`Office (JPO), the Korean Intellectual Property Office (KIPO), the State Intellectual Property Office of the People‘s
`Republic of China (SIPO), the World Intellectual Property Organization (WIPO), and any other foreign intellectual
`property office participating with the USPTO in a bilateral or multilateral priority document exchange agreement in
`which a foreign application claiming priority to the instant patent application is filed, access to: (1) the instant patent
`application-as-filed and its related bibliographic data, (2) any foreign or domestic application to which priority or
`benefit is claimed by the instant application and its related bibliographic data, and (3) the date of filing of this
`Authorization. See 37 CFR 1.14(h)(1).
`
`B. Search Results from U.S. Application to EPO - Unless box B in subsection 2 (opt-out of authorization) is
`checked, the undersigned hereby grants the USPTO authority to provide the EPO access to the bibliographic
`data and search results from the instant patent application when a European patent application claiming priority to
`the instant patent application is filed. See 37 CFR 1.14(h)(2).
`
`The applicant is reminded that the EPO‘s Rule 141(1) EPC (European Patent Convention) requires applicants to
`submit a copy of search results from the instant application without delay in a European patent application that
`claims priority to the instant application.
`
`2. Opt-Out of Authorizations to Permit Access by a Foreign Intellectual Property Office(s)
`
`A. Applicant DOES NOT authorize the USPTO to permit a participating foreign IP office access to the
`instant application-as-filed.
`If this box is checked, the USPTO will not be providing a participating foreign IP
`office with any documents and information identified in subsection 1A above.
`
`B. Applicant DOES NOT authorize the USPTO to transmit to the EPO any search results from the instant
`patent application. If this box is checked, the USPTO will not be providing the EPO with search results from
`the instant application.
`
`NOTE: Once the application has published or is otherwise publicly available, the USPTO may provide access to
`the application in accordance with 37 CFR 1.14.
`
`
`
`
`
`#85,078,563
`
`Page # 6
`
`10 of 1119
`10 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Signature:
`NOTE: This Application Data Sheet must be signed in accordance with 37 CFR 1.33(b). However, if this
`Application
`Data Sheet is submitted with the INITIAL filing of the application fl either box A or B is n_ot checked in
`subsection 2 of the “Authorization or Opt-Out of Authorization to Permit Access” section, then this form
`must
`
`also be signed in accordance with 37 CFR 1.14(c).
`This Application Data Sheet must be signed by a patent practitioner if one or more of the applicants is a
`juristic
`entity (e.g., corporation or association). If the applicant is two or morejoint inventors, this form must be signed by a
`patent practitioner, a_H joint inventors who are the applicant, or one or more joint inventor-applicants who have been
`given
`power of attorney (e.g., see USPTO Form PTO/AlA/81) on behalf of a_H joint inventor-applicants.
`See 37 CFR 1.4(d) for the manner of making signatures and certifications.
`
`
`
`signature mm Wu/
`
`Name
`
`Hui-Ju Wu, Ph.D.
`
`RegistrationNumber
`
`2016-09-06
`
`57,209
`
`
`
`#85,078,563
`
`Page # 7
`
`11 of 1119
`11 of 1119
`
`New 09/06/2016
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Declaration, Power ofAttorney and Petition
`
`Page 1 of 4
`0000057672
`
`We (1.), the undersigned i1wentor{s), hereby declarefis) that:
`
`My residence, post office address and citizenship are as stated below next to my name,
`
`We (I) believe that we are (I am) the original, first, and joint (sole) inventor(s} of the subject matter which is claimed
`and for which a patent is sought on the invention entitled
`
`the specification of which
`
`[ I is attached hereto.
`
`[]wasfiledon
`
`Application Serial No.
`
`and amended on
`
`.
`
`.2
`‘
`
`
`as
`
`.
`
`.
`
`[x] was filed as PCT international application
`
`Number .,
`
`on
`
`:-
`.__.WM.
`
`and was amended under PCT Article 19
`
`
`
`on
`
`{if applicable)
`
`We (I) hereby state that we (1}have reviewed and understand the contents of the abovezidentified specification,
`including the claims, as amended by any ammdmem referred to above.
`
`We (I) acknowledge the duty to disclose information known to be material to the patentability of this application
`as defined in Section 1.56 of Title 37 Code of Federal Regulations.
`
`We (I) hereby claim foreign Priority benefits under 35 U.S.C. § 11931) n ((1)01- § 3650)) of any foreign application(s)
`for patent or inventor’s ceztificate, or § 36591) of any PCT Intemalional Application which designated at lewd one country
`other than the United States, lieted below and have also identifier]. below, by checking the box, any foreign application for
`patent or inventor's certificate, or PCT International Application having a filing date before that of the application on
`which priority is claimed. Prior Foreign Application(s)
`
`
`
`Application No.
`
`Country
`
`Dayflvlontthear
`
`Priority
`Claimed
`
`1020060080390
`
`06120309.?
`
`Germany
`
`Europe
`
`21 Februaxy 2006
`
`07 September 2006
`
`[x] Yes
`
`[x] Yes
`
`[] No
`
`{ ] No
`
`pduspctrdf
`
`12 of 1119
`12 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`We (I) hereby claim the benefit under Title 35, United States Codes, § 119(e) of any United States provisional
`application(s) listed below.
`
`
`{Application Number)
`>
`
`
`
`(Filing Date)
`
`
`(Application Number)
`
`7
`
`7
`
`' (Filing Date)
`
`Page 2 of 4
`0000057672
`
`We (1)11ereby claim the benefit under 35 U.S.C. § 120 of any United States application(s), or § 36502) of any PCT
`Intemational Application designating the United States, listed below and, insofar as the subject matter of each of the
`claims of this application is not disclosed in the pfior United States or PCT International Application in the manner
`provided by the first paragraph of 35 U.S.C. § 112, I acknowledge the <31in to disclose information which is material to
`patentahility as defined in 37CFR § 1 .56 which became available between the filing date of the prior application and the
`national or PCT httemational filing date of this application.
`
`Application Serial No.
`
`Filing Date
`
`Status (pending, patented,
`abandoned)
`
`
`
`
`
`
`
`
`
`[hereby appoint the legistercd Practitionefls) associated with Customer No. 23416 to prosecute this application and to
`transact all business in the Patent and Trademark Office connected therewith. Direct all correspondence to Customer Number
`23416 .
`
`We (I) declare that all statements made herein of our (my) own knowledge are true and that all statements made
`on information and belief are believed to be true; and further that these statements were made with the knowledge that willful
`false statements and the like so made are punishable by fine or imprisonment, or both, under Section 1001 of
`Title 18 of the United States Code and that such willful false statements may jeopardize the validity of the application
`or any patent issuing thereon.
`
`
`
`
`
`
`pduspchrdf
`
`13 of 1119
`13 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Page 3 of 4
`0000057672
`
`Peira Cirpus
`NM OF SOLE OR FIRST INVENTOR
`
`
`
`Residence:
`Otto—Hahn-S Ir. 7
`67 165 “raid—see
`Germany
`Citizen of Germany
`
`
`
`Post Offica Addmss: same as residence
`
`Jfirg Bauer
`NARIE OF SECOND JOINT MENTOR
`
`Residence:
`Maxburgsms
`67 1 17 Limburgerhof
`. Germany
`.
`‘
`_
`..:
`-
`‘
`3 W Citizen of Germany
`
`‘
`..
`.
`, {if}?
`/ I; -.
`,
`Post Office Address: same as residence
`
`fez-g“ Saéafliipgfl'
`
`
`Xiao Qiu
`NAME OF THERE JOINT WOR
`
`, x? K
`
`Signature of Inventor
`
`Residence:
`403 Kendardine Road
`Saskamon Sk. S715? 385
`Canada.
`Citizen of Canada
`
`Post Office Addmss; same: as residence
`
`
`
`Gruohai Wu
`NAl‘v-[B OF FOURTH JOINT INVENTOR
`’
`»
`
`Residence:
`2103 Kcndardine Road,
`Saskatoon Sk. S7N 355
`Canada
`Citizen of Canada
`
`
`
`
` \f, ‘»
`
`
`Signatuxe of Inventor
`I
`r
`f_
`Dmycfiwomew (figqu— .1
`
`Bifang Chang
`Residence:
`NAME OF FETI'H JOINT INVENTOR
`FBI, 110 Gymnasium Road
`Saskatoon, Saskatchewan, S7N 0W9
`Canada
`Citizen of Canada
`
`Past Office Address: same as residence
`
` Post Office Address: same as residence
`
`
`
`pduspcm'df
`
`14 of 1119
`14 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`Marthl Truksa
`
`NM OF SIXTH JOINT INVENIOR
`
`
`
`Signature of Inventor
`
`Residence:
`
`14339 47 Avenue N. ‘W,
`Edmontoxg AB T6H DB9
`Canada
`Citizen of Canada
`
`Post Office Address: same as residence
`
`Page 4 of4
`0000057672
`
`’E‘um Waist:
`SAME'QFSEVENTH JOINT Nmmox
`
`
`Resiécnce:
`Meawiesenstrasse 21
`68 163 Mannheim
`Germany
`Citizen of Germany
`
`
`
`pduschtdf
`
`15 of 1119
`150f1119
`
`CSIRO Exhibit 1009
`CSI RO Exhibit 1009
`
`

`

`PTO/SB/OBb (07-09)
`Approved for use through 07/31/2016. OMB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Substitute for form 1449A/B/PTO
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`
`U.S. PATENT DOCUMENTS
`
`Publication Date
`Document Number
`Number-Kind Codez (ifknown) MM'DD'YYYY
`03-25-1997
`03-28-2000
`06-1 0-2004
`04-26-2005
`1 0-01 -2002
`06-23-2009
`08—1 7-201 0
`09-02-2004
`03-1 1 -2004
`03-18—2004
`06-26-2008
`09-03-2009
`
`US-5,614,393
`US-6,043,411
`US-2004/01 1 1763
`US-6,884,921-B2
`US-6,459,01 8-B1
`US-7,550,286—B2
`US-7,777,098—B2
`US-2004/01 72682-A1
`US-2004/0049805-A1
`US-2004/0053379-A1
`US-2008/0155705-A1
`US-2009/0222951-A1
`
`Pages, Columns, Lines, Where
`Relevant Passages or Relevant
`Figures Appear
`
`Name of Patentee or
`Applicant of Cited Document
`Thomas T. L. et al.
`Nishizawa et al.
`Heinz et al.
`Browse et al.
`Knutzon
`Damude et al.
`
`Cirpus et al.
`Kinney et al.
`Lerchl et al.
`Lerchl et al.
`Zank et al.
`
`Cirpus et al.
`Lerchl et al.
`
`
`
`Cite
`No.1
`AA*
`AB*
`AC*
`AD*
`AE*
`AF*
`AG*
`AH*
`Al*
`AJ*
`AK*
`AL*
`AM*
`
`Cite
`No.1
`
`BA**
`BB**
`
`Bc-k-k
`
`01 -28-201 0
`US-2010/0021976—A1
`
`09-10-1997
`
`FOREIGN PATENT DOCUMENTS
`Publication
`Date
`MM-DD-YYYY
`
`Name of Patentee or
`Applicant of Cited Document
`
`Foreign Patent Document
`Country Codes-Number‘l-
`Kind Code5 (if known)
`WO-91/1 3972
`WO-93/06712
`
`WO-93/1 1 245
`
`06-10-1993
`
`Calgene Inc.
`Rhone-Poulenc Agrochimie
`E.I. DuPont De Nemours and
`Co.
`Pioneer Hi-Bred International,
`Inc.
`El. duPont de Nemours And
`
`Company
`Monsanto Company & Michigan
`State University
`Rhone-Poulenc Agrochimie
`Cargill, Inc.
`Carnegie Institution Of
`Washington & Monsanto Co.,
`Inc.
`
`Bioriginal Food & Science Corp.
`Soremartec S.A. & Ferrero
`
`S.p.A.
`
`Pages, Columns, Lines,
`Where Relevant Passages
`
`
`
`or Relevant Figures Appear
`
`
`
`
`09-19-1991
`04-15-1993
`
`07-07-1993
`
`05-26-1994
`
`08—1 8-1 994
`
`07-11-1996
`06-19-1997
`
`08—28-1997
`
`BD“ EP-0 550 162
`
`BE“ WO-94/11516
`
`BF” WO-94/18337
`
`BG” WO-96/21022
`BH” WO-97/21340
`
`Bl” WO-97/30582
`
`BJ**
`
`BK-k-k
`
`WO-01/85968—A2
`
`11-15-2001
`
`EP-0 794 250
`
`Examiner
`Initials*
`
`Examiner
`Initials‘
`
`
`
`
`Examiner
`Signature
`
`Date
`Considered
`
`*EXAMINER: lnitial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not
`considered. Include copy of this form with next communication to applicant.
`* CITE NO.: Those application(s) which are marked with an single asterisk (*) next to
`the Cite No. are not supplied (under 37 CFR 1.98(a)(2)(iii)) because that application was filed after June 30, 2003 or is available in the IFW. 1Applicant‘s unique
`citation designation number (optional). 2See Kinds Codes of
`3 Enter Of'tice that issued the document, by the two-letter code (WIPO Standard ST.3). 4For
`USPTO Patent Documents at wwwxusgtagov or MPEP 901.04.
`Japanese patent documents, the indication of the year ofthe reign of the Emperor must precede the serial number of the patent document. 5Kind of document by
`the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. 6Applicant is to place a check mark here if English language
`Translation is attached.
`
`#85,080,135
`
`16 of 1119
`16 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`PTO/SB/OBb (07-09)
`Approved for use through 07/31/2016. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`sttsttttte tttt tom. tttgtvtttpto
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`
`
`
`
`
`WO-98/46776
`
`WO-98/46764
`WO-98/46763
`
`WO-98/46765
`WO-99/27111
`WO-99/64616
`WO-00/12720
`WO-00/21557
`
`WO-01/59128
`WO-02/08401
`WO-02/44320
`
`WO-O2/077213
`CA-2 485 060
`DE-102 19 203
`
`WO-2004/071467
`WO-02/057464-A2
`
`WO-03/064596-A2
`WO-95/18222—A1
`
`WO-02/092540-A1
`WO-02/081668-A2
`
`WO-2005/083093-A2
`
`DE-101 02 337-A1
`
`WO-2005/012316—A2
`CA-2559360-A1
`
`WO-2005/103253-A1
`
`
`
`10-22-1998 Calgene LLC
`_
`_
`Calgene LLC & Abbott
`10 22 1998 Laboratories
`Calgene LLC & Abbott
`10-22-1998
`Laboratories
`
`Calgene LLC & Abbott
`10-22-1998 Laboratories
`06-03-1999 University of Bristol
`12-16-1999 Abbott Laboratories
`03-09-2000 Abbott Laboratories
`04-20-2000 Merck & Co., Inc.
`
`08-16-2001 BASF Aktiengesellschaft
`01-31-2002 Abbott Laboratories
`06-06-2002 Xenon Genetics Inc.
`
`10-03-2002 University of Bristol
`11-13-2003 BASF Plant Science GmbH
`11-13-2003 BASF Plant Science GmbH
`E.
`I. duPont ole Nemours and
`08-26-2004 Company
`07-25-2002 BASF Plant Science GmbH
`
`08-07-2003 Abbott Laboratories
`07-06-1995 Kirin Beer Kabushiki Kaisha
`Martek Biosciences Boulder
`11-21-2002 Corporation
`10-17-2002 Abbott Laboratories
`
`09-09-2005 BASF Plant Science GmbH
`
`07-25-2002 BASF Plant Science GmbH
`
`02-10-2005 BASF Plant Science GmbH
`09-09-2005 BASF Plant Science GmbH
`Commonwealth Scientific
`11-03-2005 And Industrial Research
`
`
`
`
`
`
`
`See US
`2004/0111763
`
`See CA 2 485 060
`
`See
`US2004/0049805
`
`See US 6,043,411
`
`See US
`2008/0155705 &
`US 2009/0222951
`See US
`2004/0053379 &
`US 2010/0021976
`See Abstract
`
`Examiner
`Signature
`
`Organisation
`
`Date
`Considered
`
`*EXAMINEFI: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation If not In conformance and not
`considered. Include copy of this form with next communication to applicant.
`* CITE NO.: Those application(s) which are marked with an single asterisk (*) next to
`the Cite No. are not supplied (under 37 CFFI 1.98(a)(2)(iii)) because that application was filed after June 30, 2003 or is available in the IFW. 1Applicant‘s unique
`citation designation number (optional). 2See Kinds Codes of
`3 Enter Of'tice that issued the document, by the two-letter code (WIPO Standard ST.3). 4For
`USPTO Patent Documents at www.mptmgov or MPEP 901.04.
`Japanese patent documents, the indication of the year ofthe reign of the Emperor must precede the serial number of the patent document. 5Kind of document by
`the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. 6Applicant is to place a check mark here if English language
`Translation is attached.
`
`#85,080,135
`
`17 of 1119
`17 of 1119
`
`CSIRO Exhibit 1009
`CSIRO Exhibit 1009
`
`

`

`PTO/SB/OBb (07-09)
`Approved for use through 07/31/2016. OMB 0651-0031
`US. Patent and Trademark Office; US. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`stttsttttte tttt tom. tttgtvtttpto
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`
`
`
`
`
`
`
`Examiner
`Initials
`
`NON PATENT LITERATURE DOCUMENTS
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item (book,
`magazine, journal, serial, symposium, catalog, etc.), date, page(s), volume-issue number(s), publisher, city and/or
`country where published.
`“Danio rerio Polyunsaturated Fatty Acid Elongase Protein”, GenBank Database Accession No.
`AAN77156, February 15, 2006.
`Cronan, J.E. et al., “Biosynthesis of Membrane Lipids”, in “E. coli und Salmonella”, Section B2,
`Neidhardt, F.C. et al. eds., ASM Press, Washington, DC, (1996), pp. 612-636.
`Gerhardt, 8., "Fatty Acid Degradation in Plants", Prog. Lipid Res. 31 :4 (1992), pp. 417-446.
`Wada, H. et al., "Enhancement of Chilling Tolerance of a Cyanobacterium by Genetic
`Manipulation of Fatty Acid Desaturation", Nature 347 (1990), pp. 200-203.
`Yu, R. et al., "Production of Eicosapentaenoic Acid by a Recombinant Marine Cyanobacterium,
`Synechococcus sp.", Lipids, 35:10 (2000), pp. 1061-1064.
`Magnuson, K. et al., "Regulation of Fatty Acid Biosynthesis in Escherichia CO/I", Microbiological
`Reviews, 57:3 (1993), pp. 522-542.
`Akimoto, M. et al., "Carbon Dioxide Fixation and Polyunsaturated Fatty Acid Production by the
`Red Alga Porphyridium Cruentum", Applied Biochemistry and Biotechnology 73 (1998), pp. 269-
`278.
`
`Stymne, S., "Biosynthesis of ‘Uncommon‘ Fatty Acids and Their Incorporation into
`Triacylglycerols", Biochemistry and Molecular Biology of Membrane and Storage Lipids of
`Pla